These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
715 related items for PubMed ID: 33164934
1. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease. Richter N, Bischof GN, Dronse J, Nellessen N, Neumaier B, Langen KJ, Drzezga A, Fink GR, van Eimeren T, Kukolja J, Onur OA. J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934 [Abstract] [Full Text] [Related]
2. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment. King-Robson J, Wilson H, Politis M, Alzheimer’s Disease Neuroimaging Initiative. J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079 [Abstract] [Full Text] [Related]
5. Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity. Huijbers W, Schultz AP, Papp KV, LaPoint MR, Hanseeuw B, Chhatwal JP, Hedden T, Johnson KA, Sperling RA. J Neurosci; 2019 Jan 16; 39(3):548-556. PubMed ID: 30482786 [Abstract] [Full Text] [Related]
11. Alzheimer's pathology targets distinct memory networks in the ageing brain. Maass A, Berron D, Harrison TM, Adams JN, La Joie R, Baker S, Mellinger T, Bell RK, Swinnerton K, Inglis B, Rabinovici GD, Düzel E, Jagust WJ. Brain; 2019 Aug 01; 142(8):2492-2509. PubMed ID: 31199481 [Abstract] [Full Text] [Related]
12. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden. Buckley RF, Hanseeuw B, Schultz AP, Vannini P, Aghjayan SL, Properzi MJ, Jackson JD, Mormino EC, Rentz DM, Sperling RA, Johnson KA, Amariglio RE. JAMA Neurol; 2017 Dec 01; 74(12):1455-1463. PubMed ID: 28973551 [Abstract] [Full Text] [Related]
13. Hippocampal [18F]flortaucipir BPND corrected for possible spill-in of the choroid plexus retains strong clinico-pathological relationships. Wolters EE, Ossenkoppele R, Golla SS, Verfaillie SC, Timmers T, Visser D, Tuncel H, Coomans EM, Windhorst AD, Scheltens P, van der Flier WM, Boellaard R, van Berckel BN. Neuroimage Clin; 2020 Dec 01; 25():102113. PubMed ID: 31835238 [Abstract] [Full Text] [Related]
14. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease. Halawa OA, Gatchel JR, Amariglio RE, Rentz DM, Sperling RA, Johnson KA, Marshall GA, Alzheimer’s Disease Neuroimaging Initiative. Alzheimers Res Ther; 2019 Jan 31; 11(1):14. PubMed ID: 30704519 [Abstract] [Full Text] [Related]
16. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease. Okafor M, Nye JA, Shokouhi M, Shaw LM, Goldstein F, Hajjar I. J Alzheimers Dis; 2020 Jan 31; 74(2):589-601. PubMed ID: 32065800 [Abstract] [Full Text] [Related]
18. Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages. Schwarz AJ, Yu P, Miller BB, Shcherbinin S, Dickson J, Navitsky M, Joshi AD, Devous MD, Mintun MS. Brain; 2016 May 31; 139(Pt 5):1539-50. PubMed ID: 26936940 [Abstract] [Full Text] [Related]
19. Associations of informant-based sleep reports with Alzheimer's disease pathologies. Shokouhi S. Clin Interv Aging; 2019 May 31; 14():1631-1642. PubMed ID: 31571843 [Abstract] [Full Text] [Related]
20. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β. Therriault J, Benedet AL, Pascoal TA, Mathotaarachchi S, Chamoun M, Savard M, Thomas E, Kang MS, Lussier F, Tissot C, Parsons M, Qureshi MNI, Vitali P, Massarweh G, Soucy JP, Rej S, Saha-Chaudhuri P, Gauthier S, Rosa-Neto P. JAMA Neurol; 2020 Apr 01; 77(4):470-479. PubMed ID: 31860000 [Abstract] [Full Text] [Related] Page: [Next] [New Search]